Navigation Links
Crowdfunding Expert Kendall Almerico Discusses Scientists Using Crowdfunding to Replace Research Grants
Date:9/13/2013

Tampa, FL (PRWEB) September 13, 2013

Crowdfunding expert Kendall Almerico, CEO of crowd funding site ClickStartMe, recently discussed how scientists have turned to crowdfunding to underwrite research, rather than relying solely on grants. “Scientists are seeking non-traditional routes to underwrite research, like crowdfunding,” crowd funding expert Almerico says. “Public grants and investments are drying up for an increasing number of scientists, leaving them to seek alternative sources of money. And crowdfunding is filling that void.”

With lack of funding forcing many scientists to delay or cancel research work, crowdfunding is a natural fit, Almerico says. Almerico cited a recent Washington Times article that discussed how scientist Ethan Perlstein had turned to the Internet, social media and crowdfunding to raise money for his efforts. “This scientist repeated the oft-heard mantra about government grant funding drying up,” Almerico said. “But he went the crowdfunding route, and raised the funding he needed to pursue his research.”

Almerico notes that Perlstein raised more than $25,000 for his project on drug discovery. Perlstein said that crowdfunding projects will have greater success if researchers put sufficient energy into their campaign and even tweeted that “crowdfunding is the gateway drug for independent scientists.”

About Kendall Almerico

Crowdfunding expert Kendall Almerico is the CEO of ClickStartMe, the crowdfunding site that provides individuals, organizations and businesses with an easy-to-use website to raise funds through online crowdfunding. Almerico is a nationally recognized crowdfunding expert and has been interviewed internationally on the topic, appeared on national talk radio programs discussing crowdfunding, and has been quoted in major news sources including the New York Daily News. Almerico is available for interviews and speaking engagements by contacting media at clickstartme.com or by calling 813.410.4658.

Source: Source: http://www.washingtontimes.com/news/2013/sep/3/scientists-discover-crowdfunding-as-a-way-of-repla/?utm_source=RSS_Feed&utm_medium=RSS

Read the full story at http://www.prweb.com/releases/crowdfundingexpert/kendallalmerico/prweb11101912.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pure Transplant Solutions Launches Crowdfunding Campaign for Its Novel Technology Poised to Change the Future of Organ Transplantation
2. Crowdfunding Expert Kendall Almerico Discusses Crowdfunding for Science
3. New Crowdfunding Platform, ScitechStarter, Focuses on Science and Technology Innovators
4. MRIGlobal Engages Industry Expert in Expansion of Molecular Diagnostic Division
5. Renowned Lab Compliance Expert Ludwig Huber to Conduct ComplianceOnline Seminar on Analytical Instrument Qualification and System Validation
6. Dwaine Rieves, MD, Anthony Di Santo, PhD and Joachim Vollmar, MSc Join NDA Partners as Premier Expert Consultants
7. LIVE Twitter Chat Featuring Next-Generation Sequencing Expert from The Children’s Hospital of Philadelphia
8. Noted Herb Expert Joins American Botanical Council as Chief Science Officer
9. Laser Damage Experts to Converge in Boulder for 45th Meeting in SPIE-Sponsored Series
10. Belatrix Software Kicks off Major Innovation Effort and Invites Innovation Expert to Share How Agile + Design Thinking Accelerate Product Innovation
11. NDA Partners Introduces New Premier Expert Consultants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 Research and Markets has ... report to their offering. ... The Global Market for Bioproducts ... 2016 at a CAGR of 8.9%, This ... bioproducts into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company Cool ... financing and note conversion to commercialize its Cool Terra ... focused on developing products that are simultaneously profitable as ... in the last 18 months. This latest round of ... Venture Partners. The company,s primary product, ...
Breaking Biology Technology:
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist Medical ... its new chief executive officer (CEO). Freischlag joins the ... John D. McConnell , M.D., who last year announced ... the Medical Center, after leading it since 2008.   ... scope of Wake Forest Baptist,s academic health system, which ...
Breaking Biology News(10 mins):